Docstoc

Download article as PDF - Hampton Pharmaceuticals secures

Document Sample
Download article as PDF - Hampton Pharmaceuticals secures Powered By Docstoc
					News
Hampton Pharmaceuticals secures exclusive rights to Arlevert® in UK & Ireland
6th May 2009, Watford, UK

Hampton Pharmaceuticals announces today that it has secured exclusive sales and marketing rights in
the UK & Ireland for the vertigo product Arlevert® (cinnarizine 20mg & dimenhydrinate 40mg) from
German pharmaceutical company Hennig Arzneimittel GmbH.

Arlevert was developed by Hennig Arzneimittel and has been on the market in Germany for a number
of years where it is the market leading treatment for vertigo (source: IMS, April 2009). Arlevert is the
only dual action treatment indicated for the treatment of vertigo symptoms of both central and / or
peripheral origin (source: SmPC April 2009).

Commenting on the announcement, Andrew Trouton, General Manager of Hampton Pharmaceuticals said:

“This is a significant milestone for us to secure the rights for such an important product as Arlevert.
Arlevert fits our target product profile perfectly as it brings fresh hope to many suffers of vertigo
where the last new product in this area was launched over 3 decades ago. We hope to be able to
bring relief to many more patients in the coming months and years”

Dr Kai Schleenhain, Managing Partner of Hennig Arzneimittel said:

“Arlevert is our flagship brand and has brought relief to millions of patients with Vertigo throughout
Germany. We are very pleased to have Hampton as our partners in the UK & Ireland”.

Enquiries:
Hampton Pharmaceuticals Limited
Andrew Trouton Tel: + 44 (0) 1923 204322
Email: andrew@hamptonpharma.co.uk

Hennig Arzneimittel GmbH & Co KG
Dr Kai Schleenhain Tel: + 49 (0) 6145 508136




        Hampton Pharmaceuticals Ltd. Hampton House, Regal Way, Watford, Hertfordshire WD24 4YJ
Notes to editors

Hampton Pharmaceuticals Limited
Hampton was formed in February 2009 and is a privately owned speciality pharmaceutical company
which markets and distributes niche prescription brands throughout the UK & Ireland. With private
equity backing Hampton intends to build a portfolio of brands in areas of unmet clinical need.
Hampton is based at it’s combined office and warehouse facility in Watford, Hertfordshire.

Arlevert and Vertigo
Vertigo is a false sense of motion or spinning that may cause dizziness or nausea. It can occur as a
result of a problem with the central nervous system ('central vertigo') or if there is a problem with
the inner ear ('peripheral vertigo'). Arlevert is indicated to treat both central and peripheral
vestibular vertigo and is the only combination product available in the UK to effectively do so.

Hennig Arzneimittel GmbH & Co KG
Based near Frankfurt, Hennig Arzneimittel is one of the oldest research-based private pharmaceutical
companies in Germany. They celebrated their 110th anniversary last year. Hennig combines a
domestic sales force and the most advanced manufacturing facilities to address the German
healthcare market. Their research and development facilities focus on an evidence based approach
to the development of pharmaceutical products.




        Hampton Pharmaceuticals Ltd. Hampton House, Regal Way, Watford, Hertfordshire WD24 4YJ